Tag: Monoclonal

First Patients in NIH ACTIV-3 Clinical Trial Enroll in Dallas

sarah JonasFeature

On Wednesday in Dallas, just one day after the initiative was launched by the National Institutes of Health (NIH), Baylor Scott & White Research Institute enrolled the first patient in the world for the ACTIV-3 clinical trial. A second patient was enrolled the following day.